Relmada Therapeutics: A Promising Depression Focused Player For 2020

Relmada Therapeutics: A Promising Depression Focused Player For 2020
Relmada Therapeutics’ lead asset, REL-1017 can be a game-changer in depression indication. The company has sufficient funds to sustain its operations. Investors should consider risks such as business concentration risk, R&D failure risk, and commercial uptake uncertainties. Today, we will study why Relmada Therapeutics (NASDAQ:RLMD) is an …
News story posted on 2020-02-17T16:55:00.0000000Z